Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, March 15, 2019

Ipsilesional Mu Rhythm Desynchronization and Changes in Motor Behavior Following Post Stroke BCI Intervention for Motor Rehabilitation

I can't see how any of this helps. I don't see where an objective damage starting point is measured so there is no way to know exactly who might be helped by this. 

Ipsilesional Mu Rhythm Desynchronization and Changes in Motor Behavior Following Post Stroke BCI Intervention for Motor Rehabilitation

  • 1Department of Radiology, University of Wisconsin–Madison, Madison, WI, United States
  • 2Department of Kinesiology, University of Wisconsin–Madison, Madison, WI, United States
  • 3Institute for Clinical and Translational Research, University of Wisconsin–Madison, Madison, WI, United States
  • 4Department of Educational Psychology, University of Wisconsin–Madison, Madison, WI, United States
  • 5Center for Women’s Health Research, University of Wisconsin–Madison, Madison, WI, United States
  • 6Department of Neurology, University of Wisconsin–Madison, Madison, WI, United States
  • 7Department of Biomedical Engineering, University of Wisconsin–Madison, Madison, WI, United States
  • 8Neuroscience Training Program, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States
  • 9Department of Psychology, University of Wisconsin–Madison, Madison, WI, United States
  • 10Clinical Neuroengineering Training Program, University of Wisconsin–Madison, Madison, WI, United States
  • 11Medical Scientist Training Program, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States
  • 12Department of Electrical and Computer Engineering, University of Wisconsin–Madison, Madison, WI, United States
  • 13Department of Materials Science and Engineering, University of Wisconsin–Madison, Madison, WI, United States
  • 14Department of Neurological Surgery, University of Wisconsin–Madison, Madison, WI, United States
  • 15Department of Psychiatry, University of Wisconsin–Madison, Madison, WI, United States
Loss of motor function is a common deficit following stroke insult and often manifests as persistent upper extremity (UE) disability which can affect a survivor’s ability to participate in activities of daily living. Recent research suggests the use of brain–computer interface (BCI) devices might improve UE function in stroke survivors at various times since stroke. This randomized crossover-controlled trial examines whether intervention with this BCI device design attenuates the effects of hemiparesis, encourages reorganization of motor related brain signals (EEG measured sensorimotor rhythm desynchronization), and improves movement, as measured by the Action Research Arm Test (ARAT). A sample of 21 stroke survivors, presenting with varied times since stroke and levels of UE impairment, received a maximum of 18–30 h of intervention with a novel electroencephalogram-based BCI-driven functional electrical stimulator (EEG-BCI-FES) device. Driven by spectral power recordings from contralateral EEG electrodes during cued attempted grasping of the hand, the user’s input to the EEG-BCI-FES device modulates horizontal movement of a virtual cursor and also facilitates concurrent stimulation of the impaired UE. Outcome measures of function and capacity were assessed at baseline, mid-therapy, and at completion of therapy while EEG was recorded only during intervention sessions. A significant increase in r-squared values [reflecting Mu rhythm (8–12 Hz) desynchronization as the result of attempted movements of the impaired hand] presented post-therapy compared to baseline. These findings suggest that intervention corresponds with greater desynchronization of Mu rhythm in the ipsilesional hemisphere during attempted movements of the impaired hand and this change is related to changes in behavior as a result of the intervention. BCI intervention may be an effective way of addressing the recovery of a stroke impaired UE and studying neuromechanical coupling with motor outputs.
Clinical Trial Registration: ClinicalTrials.gov, identifier NCT02098265.

Introduction

Stroke

Stroke is a leading cause of acquired adult long-term disability in the United States (Benjamin et al., 2017) and occurs when blood supply to the brain is compromised, leading to functional deficits that may affect activities of daily living (ADLs). Approximately 85% of patients who suffer and survive a new or recurrent stroke in the United States each year require rehabilitation (Yang et al., 2017). Six months post-stroke, nearly 50% of survivors have some residual motor deficits (Benjamin et al., 2017). By 2050, stroke burden on the United States economy will approach $2.2 trillion (Benjamin et al., 2017). Despite advances in acute stroke care, the estimated direct and indirect costs of stroke continue to escalate and are disproportionally associated with long-term care and rehabilitation (Benjamin et al., 2017). Current standard of care seems insufficiently developed to treat long-term motor deficits, potentially further burdening patients as untreated motor impairment can lead to deconditioning and underutilization of the affected upper extremity (UE), a consequence deemed, learned non-use (LNU) (Schaechter, 2004).

Customary Care and the Opportunities for Improvement

Several rehabilitation techniques are traditionally used for stroke recovery including conventional physical-occupational-speech therapies, provided in acute care settings as well as newer motor therapies such as constraint-induced movement therapy (CIMT), robot-aided therapy, transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), and virtual reality (VR) (Kollen et al., 2006; Lindenberg et al., 2010; Fleet et al., 2014; Young et al., 2014a,b,c; Laver et al., 2015; Song et al., 2015; Babaiasl et al., 2016; Smith and Stinear, 2016). Importantly, a much different level of evidence exists for CIMT and traditional therapies than experimental therapies such as tDCS and VR-based approaches. Existing pharmacological treatments, Botox injections for example, and traditional physical therapy methods primarily serve to treat symptoms associated with stroke (Benjamin et al., 2017) and may not focus on bringing about basic changes to the underlying impaired brain function associated with relevant post-stroke pathologies. Patients with UE motor impairment traditionally receive rehabilitation regimens that involve passive, repetitive movement of the impaired limb without directly linking brain activity to these movements (Dromerick et al., 2009). Whereas passive movement repetition can be an effective rehabilitation strategy, recovery can be slow, and suboptimal. In contrast, linking brain activity to movement is important for motor skill learning (e.g., walking, running, throwing, writing, etc.) and the formation of central to peripheral connections. Leveraging this innate and robust motor learning circuitry, harnessing brain plasticity (Thakor, 2013), may be the next step toward improve patient outcomes.

Motor Recovery

Research suggests that motor recovery post-stroke, similar to motor learning, requires specific internal and external environmental conditions (Power et al., 2011; Wenger et al., 2017). For example, lesion load is a limiting factor as sufficient existing neural-architecture is needed for motor recovery to occur (Power et al., 2011). Recovery likely manifests either by the return of function to surviving neural architecture, or via neural reorganization and neural network remapping of proximal (i.e., near-by) neural architecture (Gazzaniga, 2005; Jones, 2017). Perhaps such processes may even be related. If neuroplasticity in the motor system, though likely attenuated by age, is continuous (Gazzaniga, 2005) over the life course (Power et al., 2011; Wenger et al., 2017), long-studied learning theories such as Hebbian plasticity and classical conditioning might be better integrated in treatment designs to aid recovery of stroke impaired UE motor capacities (Power et al., 2011; Remsik et al., 2016). The incorporation of neurorehabilitation techniques has yielded operational clinical therapies and devices (Pfurtscheller et al., 1997, 2005; Neuper and Pfurtscheller, 2001; Pineda, 2005; Felton et al., 2007; Schalk et al., 2008; Power et al., 2011; Kuiken et al., 2013; Young et al., 2014a; Wenger et al., 2017). As a number of existing approaches suffer from issues of high cost, passive movement repetition, large equipment, personnel and time constraints it is crucial efforts are made to pursue more expedient and efficacious means of rehabilitation, improve our quality of care, and better serve our survivors.

Sensorimotor Rhythms

Human brain rhythms associated with motor output, sensorimotor rhythms (SMRs), are recorded superficial to the motor and somatosensory cortical strip of the brain (electrode sites C3 and C4) and originate according to homuncular organization (Pfurtscheller et al., 1997; Birbaumer et al., 2006). At the motor cortical strip (generally, Brodmann areas 3–6), each brain hemisphere desynchronizes with imagined, attempted, and also preparation of movement. This phenomenon is known as event-related desynchronization (ERD). Specific frequency bands have been associated with specific aspects of event-related motor behaviors (Pfurtscheller et al., 1997, 2005; Felton et al., 2007; Schalk et al., 2008; Song et al., 2014; Young et al., 2014b). In normal effortful movement, Mu rhythms of the contralateral cortex are desynchronized and attenuated (ERD) as movements are planned and executed (Pfurtscheller et al., 1997). This is followed by an increased presence of Beta rhythm ERD in the contralateral motor cortex which is associated with the later stages of motor command output and control (Pineda, 2005). After the completion, or at the cessation of movement, the SMRs in Mu and Beta frequency bands synchronize (ERS). ERD and ERS were key elements in the development and use of early BCIs for the rehabilitation of motor functions (Pfurtscheller et al., 1997, 2005; Nam et al., 2011). The early designs confirmed that ERD or ERS in specific spatial areas and neural networks (e.g., thalamocortical networks, frontoparietal networks) associated with a task or triggered events can be utilized to control a device or output command (Pfurtscheller et al., 1997; Neuper and Pfurtscheller, 2001).
Mu and Beta sensorimotor rhythms (SMRs) in human subjects are recorded exclusively over sensorimotor areas at frequencies of about 10–20 Hz (Pfurtscheller et al., 1997; Birbaumer et al., 2006). Two basic strategies in SMR-based control have been introduced for motor rehabilitation in stroke patients: motor imagery (Wolpaw et al., 1991; Ortner et al., 2012; Irimia et al., 2016) and attempted movement-based approaches (Wolpaw et al., 1991; Schalk et al., 2004; Young et al., 2014a,b,c). Either approach utilizes essentially overlapping neural architecture to provide input signals (electrophysiological recordings by the EEG cap) to the BCI. The authors of this study designed the protocol to utilize attempted hand movements during the intervention according to the logic that a motor therapy intended to restore volitional motor function of the affected UE should utilize voluntary attempted movements of that impaired hand in a continuous effort to improve the participant’s UE capacity and performance.

Brain–Computer Interface (BCI) and Electroencephalography for Assistive Design

Noninvasive brain–computer interfaces (BCIs), which utilize ancillary adjuvant peripheral devices and electrical muscle stimulation, as well as invasive BCI approaches with electrodes implanted in the skull, have been introduced (Wolpaw et al., 1991; Leuthardt et al., 2004; Schalk et al., 2004, 2008; McFarland et al., 2006; Felton et al., 2007) as contemporary intervention and rehabilitation techniques following neural disease or trauma, such as stroke. Devices similar to what was utilized in this research are controlled by input signals generated by scalp electroencephalographic (EEG) recordings from electrodes superficial to the sensorimotor cortices. EEG signals associated with various components of voluntary movement are identified and translated into a device command or specified output (Pfurtscheller et al., 1997, 2005; Felton et al., 2007; Schalk et al., 2008; Wilson et al., 2012), like activation of an FES pad (Song et al., 2014; Young et al., 2014a,b). BCIs can monitoring volitional modulation of electrical brain rhythms and execute an augmentative, facilitative, or rehabilitative command in the presence or absence of such signals.

More at link

Safety and efficacy of recovery-promoting drugs for motor function after stroke: A systematic review of randomised controlled trials

A useless conclusion since protocols weren't identified on how to use those drugs.  I would fire the mentors and senior researchers that allowed such a lazy objective to be researched.

Safety and efficacy of recovery-promoting drugs for motor function after stroke: A systematic review of randomised controlled trials


Abstract

OBJECTIVE:

To investigate the efficacy and safety of drug interventions to promote motor recovery post-stroke.(We need protocols, NOT THIS CRAPOLA.)

DATA SOURCES:

CENTRAL, CINAHL, Embase, MEDLINE, SCOPUS and Web of Science.

STUDY SELECTION:

Published human randomized controlled trials in which the primary intervention was a drug administered to promote motor recovery post-stroke, vs placebo.

DATA EXTRACTION:

Standardized pro forma used to extract safety and efficacy data; Cochrane Collaboration risk of bias assessment tool performed to assess risk of bias.

DATA SYNTHESIS:

Fifty randomized controlled trials from 4,779 citations were included. An overall trend of high risk of attrition (n = 27) and reporting bias (n = 36) was observed. Twenty-eight different drug interventions were investigated, 18 of which demonstrated statistically significant results favouring increased motor recovery compared with control intervention. Forty-four studies measured safety; no major safety concerns were reported.

CONCLUSION:

Candidate drug interventions promoting motor recovery post-stroke were identified, specifically selective serotonin reuptake inhibitors and levodopa; however, the high risk of bias in many trials is concerning. Drugs to improve motor function remain an important area of enquiry. Future research must focus on establishing the correct drug intervention to be administered at an optimal dose and time, combined with the most effective adjuvant physical therapy to drive stroke recovery.

KEYWORDS:

rehabilitation; stroke; pharmaceutical preparations
PMID:
30805655
DOI:
10.2340/16501977-2536
Free full text(Where?)

Thursday, March 14, 2019

Whole-brain magnetic resonance imaging of plaque burden and lenticulostriate arteries in patients with different types of stroke

But what do you do with the results of this research? How will it be used to benefit stroke survivors?

Whole-brain magnetic resonance imaging of plaque burden and lenticulostriate arteries in patients with different types of stroke

First Published February 26, 2019 Research Article
Large-vessel atherosclerotic disease is an important pathogenesis of deep-perforator infarction (DPI). However, altered vessel walls of intracranial large arteries and distribution of small arteries in DPI are unclear because of the limited resolution of current imaging techniques. In this study the intracranial plaque burden and lenticulostriate artery (LSA) distribution in patients with recent DPI and non-DPI using whole-brain vessel-wall imaging (WB-VWI) were investigated.
A total of 44 patients with recent DPI (23 patients) or non-DPI (21 patients) due to intracranial atherosclerotic disease were prospectively enrolled. WB-VWI was performed in all the patients using a three-dimensional T1-weighted vessel-wall magnetic resonance technique. Hemispheres with DPI and non-DPI were considered as the DPI group and non-DPI group, respectively. Hemispheres without a history of stroke were the control group. The intracranial plaque burden was compared between the DPI and non-DPI groups. The number and length of visualized LSA branches among DPI, non-DPI, and control groups were also evaluated.
A total of 77 hemispheres were analyzed (23 in the DPI group, 21 in the non-DPI group, and 33 in the control group). Plaque burden was lower (p = 0.047) in the DPI group (82.0 ± 45.9 mm3) compared with the non-DPI group (130.9 ± 90.3 mm3). There was a significant reduction (p = 0.002) in length of visualized LSA branches in the DPI group (74.1 ± 21.7 mm) compared with the control group (104.6 ± 33.3 mm).
WB-VWI enables the combination of vessel-wall and LSA imaging in one image setting, which can provide information about plaque burden and LSA distribution.

Extra Pounds May Boost Stroke Survival

But those extra pounds will make your balance and walking recovery much more difficult.  I can't imagine the difficulty level of getting up off the floor when half your body doesn't work and obese.

Extra Pounds May Boost Stroke Survival

Study adds to literature supporting obesity paradox

  • by Contributing Writer, MedPage Today
PHILADELPHIA -- The "obesity paradox" -- the survival advantage of people with a higher body mass index (BMI) seen in some studies of myocardial infarction, heart failure, and other acute illnesses -- may also apply to stroke, an analysis of patients in the FAST-MAG stroke trial showed.
Elevated BMI was associated with reduced 3-month mortality and reduced disability, reported Zuolu Liu, MD, of the University of California, Los Angeles, and co-authors, in an early-release abstract from the American Academy of Neurology meeting to be held here in May.
The findings mirrored those seen 6 years ago in Europe when BMI data from the TEMPiS trial were analyzed. "We pretty much showed exactly the same thing," said Wolfram Doehner, MD, PhD, of Charite Universitatsmedizin Berlin in Germany.
"It's counterintuitive, many people say. We have been told that being overweight is bad and that we should fight obesity and overweight by whatever means," Doehner said in an interview with MedPage Today. "But it's a little more complicated than that, because when patients do have a disease, being overweight seems to change the development of the disease."
Other studies, however, have not linked obesity to better stroke outcomes, observed Tom Skyhoj Olsen, MD, PhD, of Bispebjerg University Hospital in Copenhagen.
In an analysis of 71,617 patients in Denmark, "we found no evidence of survival advantage linked to obesity," Olsen told MedPage Today, and no significant difference in risk of death by stroke when normal weight (reference), overweight (HR 0.96), and obese (HR 1.0) stroke patients were compared.
"Stroke occurred 3 years earlier in overweight patients and 6 years earlier in obese patients than in normal weight," he added.
In the current research, Liu and colleagues analyzed all acute ischemic stroke patients enrolled in the multicenter FAST-MAG study, looking at death, disability, or death defined by the modified Rankin Scale, and low stroke-related quality of life as defined on the Stroke Impact Scale.
The 1,033 patients in the FAST-MAG study had a mean age of 71, a mean NIH Stroke Scale Score of 10.6, and a mean BMI of 27.5. Less than half (45.1%) were female.
Risk of death declined linearly with higher BMI. Adjusted odds ratios for mortality declined across the BMI categories of underweight (OR 1.67), normal (reference), overweight (OR 0.85), obese (OR 0.54), and severely obese (OR 0.62).
Odds ratios for disability or death declined through the first four BMI categories -- underweight (OR 1.19), normal (reference), overweight (OR 0.78), obese (OR 0.72) -- but not for people who were severely obese (OR 0.96). Similar but non-significant trends were seen for low stroke-related quality of life.
How extra body fat may confer an advantage is unknown, but "one possible explanation is that people who are overweight or obese may have a nutritional reserve that may help them survive during prolonged illness," Liu speculated.
A limitation of the study was that all participants were from southern California and results may not be similar in other places, Liu added. However, the racial and ethnic distribution of the population in this analysis mirrored that of the national population, she said.
Disclosures were not reported.

Synergistic Benefits of Combined Aerobic and Cognitive Training on Fluid Intelligence and the Role of IGF-1 in Chronic Stroke

With no protocols written on this, this is totally useless. We need to fire the mentors and senior researchers that allowed such crap. 

Synergistic Benefits of Combined Aerobic and Cognitive Training on Fluid Intelligence and the Role of IGF-1 in Chronic Stroke

First Published February 28, 2019 Research Article
Background. Paired exercise and cognitive training have the potential to enhance cognition by “priming” the brain and upregulating neurotrophins.  
Methods. Two-site randomized controlled trial. Fifty-two patients >6 months poststroke with concerns about cognitive impairment trained 50 to 70 minutes, 3× week for 10 weeks with 12-week follow-up. Participants were randomized to 1 of 2 physical interventions: Aerobic (>60% VO2peak using <10% body weight–supported treadmill) or Activity (range of movement and functional tasks). Exercise was paired with 1 of 2 cognitive interventions (computerized dual working memory training [COG] or control computer games [Games]). The primary outcome for the 4 groups (Aerobic + COG, Aerobic + Games, Activity + COG, and Activity + Games) was fluid intelligence measured using Raven’s Progressive Matrices Test administered at baseline, posttraining, and 3-month follow-up. Serum neurotrophins collected at one site (N = 30) included brain-derived neurotrophic factor (BDNF) at rest (BDNFresting) and after a graded exercise test (BDNFresponse) and insulin-like growth factor–1 at the same timepoints (IGF-1rest, IGF-1response).  
Results. At follow-up, fluid intelligence scores significantly improved compared to baseline in the Aerobic + COG and Activity + COG groups; however, only the Aerobic + COG group was significantly different (+47.8%) from control (Activity + Games −8.5%). Greater IGF-1response at baseline predicted 40% of the variance in cognitive improvement. There was no effect of the interventions on BDNFresting or BDNFresponse; nor was BDNF predictive of the outcome. Conclusions. Aerobic exercise combined with cognitive training improved fluid intelligence by almost 50% in patients >6 months poststroke. Participants with more robust improvements in cognition were able to upregulate higher levels of serum IGF-1 suggesting that this neurotrophin may be involved in behaviorally induced plasticity.

Article available in:

Related Articles

Citing Articles: 0

Applying LDA-based pattern recognition to predict isometric shoulder and elbow torque generation in individuals with chronic stroke with moderate to severe motor impairment

Fuck, we don't care about prediction you blithering idiots. What is the protocol to resolve the shoulder impairment?  Have a stroke and try to recover with your stupidity of research.  I take no prisoners.

Applying LDA-based pattern recognition to predict isometric shoulder and elbow torque generation in individuals with chronic stroke with moderate to severe motor impairment 

  • ,
  • and
  • Email author
Journal of NeuroEngineering and Rehabilitation201916:35
  • Received: 11 September 2018
  • Accepted: 22 February 2019
  • Published:

Abstract

Background

Abnormal synergy is a major stroke-related movement impairment that presents as an unintentional contraction of muscles throughout a limb. The flexion synergy, consisting of involuntary flexion coupling of the paretic elbow, wrist, and fingers, is caused by and proportional to the amount of shoulder abduction effort and limits reaching function. A wearable exoskeleton capable of predicting movement intent could augment abduction effort and therefore reduce the negative effects of distal joint flexion synergy. However, predicting movement intent from abnormally-coupled torques or EMG signals and subsequent use as a control signal remains elusive. One control strategy that has proven viable, effective, and computationally efficient in myoelectric prostheses for use in individuals with amputation is linear discriminant analysis (LDA)-based pattern recognition. However, following stroke, shoulder effort has been shown to have a negative effect on classification accuracy of hand tasks due to the multi-joint torque coupling of abnormal synergy. This study focuses on the evaluation of an LDA-based classifier to predict individual degrees-of-freedom of the shoulder and elbow joints.

Methods

Six degree-of-freedom load cell data along with eight channels of EMG data were recorded during eight tasks (shoulder abduction and adduction, horizontal abduction and adduction, internal rotation and external rotation, and elbow flexion and extension) and used to create feature sets for LDA-based classifiers to distinguish between these eight classes.

Results

Cross-validation yielded functional offline classification accuracies (> 90%) for two of the eight classes using EMG-only, four of the eight classes using load cell-only, and six of the eight classes using a combined feature set with average accuracies of 83, 91, and 92% respectively.

Conclusions

The most common misclassifications were between shoulder adduction and internal rotation followed by shoulder abduction and external rotation. It is unknown whether the strategies used were due to abnormal synergy or other factors. LDA-based pattern recognition may be a viable control option for predicting movement intention and providing a control signal for a wearable exoskeletal assistive device. Future work will need to test the approach in a more complex multi-joint task, specifically one that attempts to tease apart shoulder abduction/external rotation and adduction/internal rotation.

Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study

Well shit what is it? There are these other pieces of research out there. We don't care about prevalence, just give us protocols to prevent it.  Or don't you understand what stroke survivor's goals are? The only goal in stroke is 100% recovery!

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018

 

 

Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study

Open AccessPublished:March, 2019DOI:https://doi.org/10.1016/S1474-4422(18)30442-3

Summary

Background

Risk of dementia after stroke is a major concern for patients and carers. Reliable data for risk of dementia, particularly after transient ischaemic attack or minor stroke, are scarce. We studied the risks of, and risk factors for, dementia before and after transient ischaemic attack and stroke.

Methods

The Oxford Vascular Study is a prospective incidence study of all vascular events in a population of 92 728 people residing in Oxfordshire, UK. Patients with transient ischaemic attack or stroke occurring between April 1, 2002, and March 31, 2012, were ascertained with multiple methods, including assessment in a dedicated daily emergency clinic and daily review of all hospital admissions. Pre-event and post-event (incident) dementia were diagnosed at initial assessment and during 5-years' follow-up on the basis of cognitive testing supplemented by data obtained from hand searches of all hospital and primary care records. We assessed the association between post-event dementia and stroke severity (as measured with the US National Institutes of Health Stroke Scale [NIHSS] score), location (ie, dysphasia), previous events, markers of susceptibility or reserve (age, low education, pre-morbid dependency, leucoaraiosis), baseline cognition, and vascular risk factors with Cox regression models adjusted for age, sex, and education. We compared incidence and prevalence of dementia in our population with published UK population age-matched and sex-matched rates.

Findings

Among 2305 patients (mean age 74·4 years [SD 13·0]), 688 (30%) had transient ischaemic attacks and 1617 (70%) had strokes. Pre-event dementia was diagnosed in 225 patients; prevalence was highest in severe stroke (ie, NIHSS >10) and lowest in transient ischaemic attack. Of 2080 patients without pre-event dementia, 1982 (95%) were followed up to the end of study or death. Post-event dementia occurred in 432 of 2080 patients during 5 years of follow-up. The incidence of post-event dementia at 1 year was 34·4% (95% CI 29·7–41·5) in patients with severe stroke (NIHSS score >10), 8·2% (6·2–10·2) in those with minor stroke (NIHSS score <3), and 5·2% (3·4–7·0) in those with transient ischaemic attack. Compared with the UK age-matched and sex-matched population, the 1-year standardised morbidity ratio for the incidence of dementia was 47·3 (95% CI 35·9–61·2), 5·8 (4·4–7·5), and 3·5 (2·5–4·8), respectively. Consequently, prevalence of dementia in 1-year survivors was brought forward by approximately 25 years in those who had severe strokes, 4 years in those who had minor strokes, and 2 years in those who had transient ischaemic attacks. 5-year risk of dementia was associated with age, event severity, previous stroke, dysphasia, baseline cognition, low education, pre-morbid dependency, leucoaraiosis, and diabetes (p<0·0001 for all comparisons, except for previous stroke [p=0·006]).

Interpretation

The incidence of dementia in patients who have had a transient ischaemic attack or stroke varies substantially depending on clinical characteristics including lesion burden and susceptibility factors. Incidence of dementia is nearly 50 times higher in the year after a major stroke compared with that in the general population, but excess risk is substantially lower after transient ischaemic attack and minor stroke.

Funding

Wellcome Trust, Wolfson Foundation, British Heart Foundation, National Institute for Health Research, and the National Institute for Health Research Oxford Biomedical Research Centre.

The effectiveness of somatosensory retraining for improving sensory function in the arm following stroke: a systematic review

You mean that you missed the Margaret Yekutiel  book about this from 2001, 'Sensory Re-Education of the Hand After Stroke'?  And still didn't write a protocol on how to do this?  How long do stroke survivors have to put up with such fucking incompetency?

The effectiveness of somatosensory retraining for improving sensory function in the arm following stroke: a systematic review

Turville ML, et al. Clin Rehabil. 2019.

Abstract

OBJECTIVE:: The aim of this study was to evaluate if somatosensory retraining programmes assist people to improve somatosensory discrimination skills and arm functioning after stroke.
DATA SOURCES:: Nine databases were systematically searched: Medline, Cumulative Index to Nursing and Allied Health Literature, PsychInfo, Embase, Amed, Web of Science, Physiotherapy Evidence Database, OT seeker, and Cochrane Library.
REVIEW METHODS:: Studies were included for review if they involved (1) adult participants who had somatosensory impairment in the arm after stroke, (2) a programme targeted at retraining somatosensation, (3) a primary measure of somatosensory discrimination skills in the arm, and (4) an intervention study design (e.g. randomized or non-randomized control designs).
RESULTS:: A total of 6779 articles were screened. Five group trials and five single case experimental designs were included ( N = 199 stroke survivors). Six studies focused exclusively on retraining somatosensation and four studies focused on somatosensation and motor retraining. Standardized somatosensory measures were typically used for tactile, proprioception, and haptic object recognition modalities. Sensory intervention effect sizes ranged from 0.3 to 2.2, with an average effect size of 0.85 across somatosensory modalities. A majority of effect sizes for proprioception and tactile somatosensory domains were greater than 0.5, and all but one of the intervention effect sizes were larger than the control effect sizes, at least as point estimates. Six studies measured motor and/or functional arm outcomes ( n = 89 participants), with narrative analysis suggesting a trend towards improvement in arm use after somatosensory retraining.
CONCLUSION:: Somatosensory retraining may assist people to regain somatosensory discrimination skills in the arm after stroke.

PMID

30798643 [ - as supplied by publisher]

Full text


Intensive upper limb neurorehabilitation in chronic stroke: outcomes from the Queen Square programme

Notice that your doctor has zilch to do with this recovery of yours, doing nothing while you do everything. Your doctor did nothing while millions of brain cells continued to die during the first week from the 5 causes of the neuronal cascade of death.

Intensive upper limb neurorehabilitation in chronic stroke: outcomes from the Queen Square programme


  1. Nick S Ward1,2,3,
  2. Fran Brander2,3,
  3. Kate Kelly2,3

Abstract

Objective Persistent difficulty in using the upper limb remains a major contributor to physical disability post-stroke. There is a nihilistic view about what clinically relevant changes are possible after the early post-stroke phase. The Queen Square Upper Limb Neurorehabilitation programme delivers high-quality, high-dose, high-intensity upper limb neurorehabilitation during a 3-week (90 hours) programme. Here, we report clinical changes made by the chronic stroke patients treated on the programme, factors that might predict responsiveness to therapy and the relationship between changes in impairment and activity.
Methods Upper limb impairment and activity were assessed on admission, discharge, 6 weeks and 6 months after treatment, with modified upper limb Fugl-Meyer (FM-UL, max-54), Action Research Arm Test (ARAT, max-57) and Chedoke Arm and Hand Activity Inventory (CAHAI, max-91). Patient-reported outcome measures were recorded with the Arm Activity Measure (ArmA) parts A (0–32) and B (0–52), where lower scores are better.
Results 224 patients (median time post-stroke 18 months) completed the 6-month programme. Median scores on admission were as follows: FM-UL = 26 (IQR 16–37), ARAT=18 (IQR 7–33), CAHAI=40 (28-55), ArmA-A=8 (IQR 4.5–12) and ArmA-B=38 (IQR 24–46). The median scores 6 months after the programme were as follows: FM-UL=37 (IQR 24–48), ARAT=27 (IQR 12–45), CAHAI=52 (IQR 35–77), ArmA-A=3 (IQR 1–6.5) and ArmA-B=19 (IQR 8.5–32). We found no predictors of treatment response beyond admission scores.
Conclusion With intensive upper limb rehabilitation, chronic stroke patients can change by clinically important differences in measures of impairment and activity. Crucially, clinical gains continued during the 6-month follow-up period.

Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: A prospective analysis of up to 347,077 individuals and 8,368 cases

Bad research since it doesn't take into account the protective effects of coffee on Parkinsons and dementia. Not complete enough research.

How coffee protects against Parkinson’s Aug. 2014 

Coffee May Lower Your Risk of Dementia Feb. 2013

 

Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: A prospective analysis of up to 347,077 individuals and 8,368 cases

American Journal of Clinical NutritionZhou A, et al. | March 12, 2019
Advertisement
Researchers used data from the UK Biobank, as well as logistic regression, to examine whether the link between habitual coffee consumption and cardiovascular disease (CVD) risk varied with CYP1A2 (a functional variant at cytochrome P450 1A2) genotype or a genetic score for caffeine metabolism (caffeine-GS). They analyzed data for 347,077 individuals, with 8,368 incident CVD cases. An elevated CVD risk was reported for nondrinkers, drinkers of decaffeinated coffee, and those who reported drinking >6 cups/day vs those drinking 1–2 cups/day (increase in odds by 11%, 7%, and 22%, respectively). A modest increase in CVD risk was observed in association with heavy coffee consumption, but genetic variants affecting caffeine metabolism had no impact on this link.
Read the full article on American Journal of Clinical Nutrition

Association of midlife diet with subsequent risk for dementia

Well shit, you are not looking carefully enough then.  I found these in 5 minutes.

Coffee May Lower Your Risk of Dementia Feb. 2013 

Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia  Dec. 2018 

Champagne Protects the Brain From Dementia  Feb. 2019 

“Bugs” in the gut might predict dementia in the brain Feb. 2019

 

 

Association of midlife diet with subsequent risk for dementia

JAMAAkbaraly TN, et al. | March 14, 2019
In this prospective cohort study involving 8,225 participants without dementia, researchers ascertained if midlife (mean age: 50 years) diet is correlated with subsequent dementia risk. According to findings, the quality of the diet evaluated during midlife was not significantly related to subsequent dementia risk.


Methods

  • This was a population-based cohort study established in 1985-1988 in which researchers assessed dietary intake in 1991-1993, 1997-1999, and 2002-2004, and followed-up for incident dementia until March 31, 2017.
  • Diet quality during midlife was assessed using the Alternate Healthy Eating Index (AHEI; diet quality score (score range, 0-110), with higher scores indicating a healthier diet.
  • The main outcome assessed was incident dementia, which was determined by electronic health records linkage.

New approach to stroke treatment could minimize brain damage

I bet nothing will be done with this, just like nothing is being done for the other causes of the neuronal cascade of death. 


1.  glutamate poisoning   March 2012
2.  excitotoxicity April 2012
3.  Capillaries that don't open due to pericytes  Sept. 2011
4.  Inflammatory action leaking through the blood brain barrier.
http://link.springer.com/article/10.1007/s12975-013-0301-2  May 2013

5.  Lysosomal Membrane Permeabilization as a Key Player in Brain Ischemic Cell Death: a “Lysosomocentric” Hypothesis for Ischemic Brain Damage Nov. 2013

Notice how long ago all this research was published. Why is your stroke hospital president still president and the board of directors still there?  I would have all of them fired for cause.

New approach to stroke treatment could minimize brain damage

A new treatment for a common type of stroke may soon be possible, thanks to a discovery by an international team of researchers led by the University of British Columbia.
In a study published today in the Journal of Experimental Medicine, researchers successfully used a new approach that significantly minimized brain damage caused by stroke in mouse models. The new approach works by targeting hemichannels—pathways that allow for the flow of chemical ions and small molecules—that are expressed by astrocytes, cells that play a protective role for neurons in the brain.
When stroke occurs, these hemichannels open and can leak toxic molecules into the space outside the astrocytes, causing inflammation and damage to neurons.
“Our study definitively confirms that hemichannels are detrimental in stroke, and that we can block them to minimize damage to the brain,” said lead author Moises Freitas-Andrade, who conducted this study as a postdoctoral research fellow at UBC and currently is a research fellow at The Ottawa Hospital Research Institute. “It’s a different approach to stroke treatment. A lot of previous research has focused on trying to protect neurons, but here we sought a way to enhance the astrocyte’s ability to protect neurons in stroke.”
The researchers focused specifically on ischemic strokes, which occur when the arteries to the brain become narrowed or blocked, resulting in severely reduced blood flow. Ischemic stroke is the most common type, accounting for about 80 per cent of all strokes, according to the Heart and Stroke Foundation of Canada.
For the study, the researchers used a genetic approach that mutated the channel proteins, called connexins, in such a way that blocks the formation of hemichannels. This allows the astrocytes to protect the neurons, significantly reducing the size of the stroke injury in the brain. The researchers also used a molecule called Gap19 to block the hemichannels, in the same stroke model, which also resulted in smaller stroke damage. Together, the two approaches demonstrate that connexin hemichannel blockers could be used as a neuroprotective agent in stroke.
The researchers also attempted to mimic “real life” stroke conditions in the study, waiting two hours after the stroke occurred before administering the drug.
“It was important for us that we used a clinically realistic treatment window, especially if we were testing a drug that could potentially be used for treatment one day,” said the study’s senior author Christian Naus, professor emeritus in UBC’s department of cellular and physiological sciences, member of the Life Sciences Institute and an associate of the Djavad Mowafaghian Centre for Brain Health at UBC. “For the average person who has a stroke, two hours could easily elapse by the time paramedics arrive and the patient is taken to hospital and starts receiving treatment. This sets the stage for a combined approach where one could not only directly treat neurons in stroke, but could also enhance the astrocytes’ ability to protect neurons under stroke conditions.”
The researchers believe the approach could also have potential use for treating other neurodegenerative conditions such as traumatic brain injury and Alzheimer’s disease.
The study also involved researchers at the Fred Hutchinson Cancer Research Centre in Seattle and Ghent University in Belgium.
“This research is a great example of how the expertise from laboratories from three different countries could not only identify the importance of these connexin hemichannels but also discover the mechanisms involved and even identify possible avenues for treatment,” said study co-author Paul Lampe of the Fred Hutchinson Cancer Research Centre.
“Through the efforts of several labs, we were able to conduct in-depth explorations of channel protein function and its effect on disease treatment and outcome,” added Luc Leybaert of Ghent University.
This research was supported by grants from the Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research, the Canada Research Chairs program, the U.S. National Institutes of Health, the Fund for Scientific Research Flanders, the Interuniversity Attraction Poles Program, and the Geneeskundige Stichting Koningin Elisabeth.

Contact

Thandi Fletcher
UBC Media Relations
Tel: 604-822-2234
Cel: 604-868-0896
Email: thandi.fletcher@ubc.ca

Luke Perry's cause of death revealed - stroke

Wrong, wrong, wrong. He died from brain damage. Until we know EXACTLY what brain damage caused the death we can never fix the problem. What part of the brain was damaged? Did the neuronal cascade of death

in the first week cause the death? Looking at the dates, Feb. 27 - Mar. 4, it seems likely the doctors were doing nothing to stem the neuronal cascade of death

in the first week, directly causing his death. Old age is not allowed on death certificates anymore, stroke should not be allowed either. 

Luke Perry's cause of death revealed - stroke

Luke Perry‘s cause of death confirms the actor died of a stroke, specifically an “ischemic cerebrovascular accident.” There were no underlying causes listed as contributing to his passing, according to the actor’s death certificate.
An ischemic stroke is most common and occurs when a blood clot blocks a blood vessel, preventing blood and oxygen from getting to a part of the brain. Perry was rushed to a Los Angeles area hospital on Feb. 27 after suffering a “massive stroke.” Doctors hoped(Hope is not a protocol, this is just pure guesswork on the doctors part. You'll have to hope your doctor is better than just hoping and praying you recover.) sedation would give his brain a chance to recover from the trauma, but he was eventually pulled off life support on March 4. His time of death is listed as 12:44 p.m.
The Beverly Hills, 90210 star’s death certificate also revealed his body was transported to Dickson, Tenn. where he was laid to rest on March 11. Perry had owned a farm in the area since 1994 where he lived part-time. The actor was shooting Riverdale in L.A. at the time of his death.
Perry was a beloved member of Dickson County. After the devastating 2010 floods, he was on the frontlines distributing water, shoes and food to those in need during the pouring rain. Many in the rural town shared sweet stories of remembrances following news of his passing.
“He acted like we were part of his family. He would always give you a hug,” one local business owner said. “I found him to be just a nice person. I enjoyed talking to him. He always knew you.”
Perry’s fiancée, Wendy Madison Bauer, was listed as the his next of kin. According to a save-the-date announcement, the private pair planned to wed in August.
“I want to express my gratitude to everyone for the outpouring of love and support,” Bauer, an actress turned therapist, said in a statement. “The countless, heartwarming stories of Luke’s generosity and kindness have been a great source of solace during this difficult time.”
“The past 11½ years with Luke were the happiest years of my life, and I am grateful to have had that time with him,” she added. “I also want to thank his children, family, and friends for their love and support. We have found comfort in one another and in the knowledge that our lives were touched by an extraordinary man. He will be dearly missed.”

039 - Low Levels of Moderate to Vigorous Physical Activity is Associated With Fewer Years Lived Free of Cardiovascular Disease: The Cardiovascular Lifetime Risk Pooling Project

Hell, I had high levels of vigorous physical activity and had the cardiovascular fitness of an athlete and still had a stroke.  Good conscience laundering but not really that helpful. I'll live some 40 years past my stroke which means I'll have lived with cardivascular disease 4/9s of my life(44%).

039 - Low Levels of Moderate to Vigorous Physical Activity is Associated With Fewer Years Lived Free of Cardiovascular Disease: The Cardiovascular Lifetime Risk Pooling Project

Session 10 - Physical Activity

039 - Low Levels of Moderate to Vigorous Physical Activity is Associated With Fewer Years Lived Free of Cardiovascular Disease: The Cardiovascular Lifetime Risk Pooling Project

Itinerary
March 8, 2019, 10:56 AM - 11:07 AM Galleria Ballroom - 3rd Floor

Authors
Amanda Paluch, Northwestern Univ, Chicago, IL; Hongyan Ning, Mercedes Carnethon, Northwestern Univ Feinberg Sch of Med, Chicago, IL; Kelley Pettee Gabriel, Univ of Texas Health Science Ctr at Houston, Sch of Public Health - Austin Campus, Austin, TX; Norrina Allen, Donald Lloyd-Jones, John Wilkins, Northwestern Univ Feinberg Sch of Med, Chicago, IL
Disclosures
 A. Paluch: None. H. Ning: None. M. Carnethon: None. K. Pettee Gabriel: None. N. Allen: None. D. Lloyd-Jones: None. J. Wilkins: None.

Abstract


Background: Quantifying the associations of moderate to vigorous intensity physical activity (MVPA) with years lived free of cardiovascular disease (CVD) allows for contextualization of the population burden and provides a metric for clinician-patient communication. We hypothesized that individuals with lower levels of MVPA during middle age will have fewer years lived free of CVD compared to those with higher levels.
Methods: A standardized z-score for MVPA was created based on participant-reported physical activity in 28,466 middle aged adults aged 40-59 years (43.6% women) in 6 U.S. prospective cohort studies. Z-scores were then categorized into quartiles for each cohort. Rates (person-years) of incident CVD and death were summed for participants up to age 95 years, or to the oldest age of observation. Irwin’s restricted mean was used to calculate years lived free from CVD and overall survival stratified by sex.
Results: Over 514,324 person-years of follow-up, 3,556 CVD events were observed. Whereas there was no difference in survival time among participants in the upper 3 quartiles, women in the lowest quartile vs. the next lowest quartile lived 3.2 fewer years and men lived 1.2 fewer years free of CVD. Survival after a CVD event was lower for women in the lowest MVPA quartile (mean±S.E: 0.07±0.32 years) compared to all other quartiles (Q2: 0.67±0.16 years to Q4: 0.96±0.16 years). Survival after CVD events was similar across all quartiles of MVPA for men, ranging from 1.1±0.05 to 1.4±0.05 years.
Conclusions: The benefits of physical activity extend multiple decades into older ages. Even modest levels of physical activity during middle age is associated with longer CVD-free survival, particularly among women.